Rise of the Resistance: Challenging Carbapenem-Resistant Gram-Negative Infections ID Week Symposium Join the Fight Against Antibiotic Resistance
In the ongoing battle against antibiotic-resistant infections, continuous education and adaptation of new strategies are crucial. This October, healthcare professionals specializing in infectious diseases and critical care have the unique opportunity to enhance their understanding and skills at the “Rise of the Resistance: Challenging Carbapenem-Resistant Gram-Negative Infections” symposium. Scheduled for October 16, 2024, this educational event is set to take place both in-person at JW Marriott Los Angeles L.A. LIVE and online at Clinical Care Options.
Educational Objectives and Agenda
The symposium aims to equip participants with the latest knowledge and techniques to tackle complex carbapenem-resistant infections. Leading experts, including
In the ongoing battle against antibiotic-resistant infections, continuous education and adaptation of new strategies are crucial. This October, healthcare professionals specializing in infectious diseases and critical care have the unique opportunity to enhance their understanding and skills at the “Rise of the Resistance: Challenging Carbapenem-Resistant Gram-Negative Infections” symposium. Scheduled for October 16, 2024, this educational event is set to take place both in-person at JW Marriott Los Angeles L.A. LIVE and online at Clinical Care Options.
Educational Objectives and Agenda
The symposium aims to equip participants with the latest knowledge and techniques to tackle complex carbapenem-resistant infections. Leading experts, including Dr. Marguerite Monogue and Dr. Michael J. Satlin, will guide attendees through case-based discussions reflecting the latest guidance recommendations and clinical data. The agenda includes:
- Introduction: Setting the stage for a deep dive into carbapenem-resistant Enterobacterales (CRE).
- Rise of the Resistance: The Evolving Landscape of CRE: An exploration of the escalating challenges posed by CRE.
- AMR in P. aeruginosa: Poster Child of “Difficult-to-Treat”: Discussing strategies for managing infections caused by antibiotic-resistant Pseudomonas aeruginosa.
- S. maltophilia: An Intrinsically Complex Clinical Challenge: Addressing the unique issues in treating Stenotrophomonas maltophilia infections.
- Questions and Answers: An opportunity for attendees to ask questions and discuss cases with the experts.
Accreditation and Continuing Education
This symposium is accredited by Clinical Care Options, LLC and offers up to 1.50 AMA PRA Category 1 Credits™ for physicians, 1.50 nursing contact hours for nurses, and 1.50 contact hours (0.15 CEUs) for pharmacists.
Who Should Attend?
This program targets healthcare professionals involved in the management of carbapenem-resistant gram-negative infections, including infectious disease specialists, critical care physicians, nurses, and clinical pharmacists. Whether you’re looking to refine your approach to antibiotic management or to stay abreast of evolving best practices, this symposium promises valuable insights and practical tools.
Practical Details
Date: October 16, 2024
Time: 11:00 AM – 1:00 PM Pacific Time (PT)
Location: JW Marriott Los Angeles L.A. LIVE, 900 W Olympic Blvd, Los Angeles, California, Platinum Ballroom E.
Virtual:
Registration
Interested participants are encouraged to register soon as both in-person and virtual options are available. This symposium is not an official event of IDWeek, nor is it sponsored, endorsed, or accredited by IDWeek.
Acknowledgement
This symposium is provided by Clinical Care Options, LLC, and supported by an educational grant from Shionogi Pharma, Inc., reflecting a commitment to high-quality, unbiased, and impactful education.
For more details and to register, click here.
Join us to be part of a crucial conversation on managing some of the most challenging infections in modern healthcare.
and Dr. Michael J. Satlin, will guide attendees through case-based discussions reflecting the latest guidance recommendations and clinical data. The agenda includes:
- Introduction: Setting the stage for a deep dive into carbapenem-resistant Enterobacterales (CRE).
- Rise of the Resistance: The Evolving Landscape of CRE: An exploration of the escalating challenges posed by CRE.
- AMR in P. aeruginosa: Poster Child of “Difficult-to-Treat”: Discussing strategies for managing infections caused by antibiotic-resistant Pseudomonas aeruginosa.
- S. maltophilia: An Intrinsically Complex Clinical Challenge: Addressing the unique issues in treating Stenotrophomonas maltophilia infections.
- Questions and Answers: An opportunity for attendees to ask questions and discuss cases with the experts.
Accreditation and Continuing Education
This symposium is accredited by Clinical Care Options, LLC and offers up to 1.50 AMA PRA Category 1 Credits™ for physicians, 1.50 nursing contact hours for nurses, and 1.50 contact hours (0.15 CEUs) for pharmacists.
Who Should Attend?
This program targets healthcare professionals involved in the management of carbapenem-resistant gram-negative infections, including infectious disease specialists, critical care physicians, nurses, and clinical pharmacists. Whether you’re looking to refine your approach to antibiotic management or to stay abreast of evolving best practices, this symposium promises valuable insights and practical tools.
Practical Details
Date: October 16, 2024
Time: 11:00 AM – 1:00 PM Pacific Time (PT)
Location: JW Marriott Los Angeles L.A. LIVE, 900 W Olympic Blvd, Los Angeles, California, Platinum Ballroom E.
Virtual:
Registration
Interested participants are encouraged to register soon as both in-person and virtual options are available. This symposium is not an official event of IDWeek, nor is it sponsored, endorsed, or accredited by IDWeek.
Acknowledgement
This symposium is provided by Clinical Care Options, LLC, and supported by an educational grant from Shionogi Pharma, Inc., reflecting a commitment to high-quality, unbiased, and impactful education.
For more details and to register, click here.
Join us to be part of a crucial conversation on managing some of the most challenging infections in modern healthcare.